Cargando…
Costs of breast cancer treatment incurred by women in Vietnam
BACKGROUND: There is a paucity of research on the cost of breast cancer (BC) treatment from the patient’s perspective in Vietnam. METHODS: Individual-level data about out-of-pocket (OOP) expenditures on use of services were collected from women treated for BC (n = 202) using an online survey and a f...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750856/ https://www.ncbi.nlm.nih.gov/pubmed/35012517 http://dx.doi.org/10.1186/s12889-021-12448-3 |
_version_ | 1784631555338010624 |
---|---|
author | Ngan, Tran Thu Ngoc, Nguyen Bao Van Minh, Hoang Donnelly, Michael O’Neill, Ciaran |
author_facet | Ngan, Tran Thu Ngoc, Nguyen Bao Van Minh, Hoang Donnelly, Michael O’Neill, Ciaran |
author_sort | Ngan, Tran Thu |
collection | PubMed |
description | BACKGROUND: There is a paucity of research on the cost of breast cancer (BC) treatment from the patient’s perspective in Vietnam. METHODS: Individual-level data about out-of-pocket (OOP) expenditures on use of services were collected from women treated for BC (n = 202) using an online survey and a face-to-face interview at two tertiary hospitals in 2019. Total expenditures on diagnosis and initial BC treatment were presented in terms of the mean, standard deviation, and range for each type of service use. A generalised linear model (GLM) was used to assess the relationship between total cost and socio-demographic characteristics. RESULTS: 19.3% of respondents had stage 0/I BC, 68.8% had stage II, 9.4% had stage III, none had stage IV. The most expensive OOP elements were targeted therapy with mean cost equal to 649.5 million VND ($28,025) and chemotherapy at 36.5 million VND ($1575). Mean total OOP cost related to diagnosis and initial BC treatment (excluding targeted therapy cost) was 61.8 million VND ($2667). The mean OOP costs among patients with stage II and III BC were, respectively, 66 and 148% higher than stage 0/I. CONCLUSIONS: BC patients in Vietnam incur significant OOP costs. The cost of BC treatment was driven by the use of therapies and presentation stage at diagnosis. It is likely that OOP costs of BC patients would be reduced by earlier detection through raised awareness and screening programmes and by providing a higher insurance reimbursement rate for targeted therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-12448-3. |
format | Online Article Text |
id | pubmed-8750856 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87508562022-01-11 Costs of breast cancer treatment incurred by women in Vietnam Ngan, Tran Thu Ngoc, Nguyen Bao Van Minh, Hoang Donnelly, Michael O’Neill, Ciaran BMC Public Health Research BACKGROUND: There is a paucity of research on the cost of breast cancer (BC) treatment from the patient’s perspective in Vietnam. METHODS: Individual-level data about out-of-pocket (OOP) expenditures on use of services were collected from women treated for BC (n = 202) using an online survey and a face-to-face interview at two tertiary hospitals in 2019. Total expenditures on diagnosis and initial BC treatment were presented in terms of the mean, standard deviation, and range for each type of service use. A generalised linear model (GLM) was used to assess the relationship between total cost and socio-demographic characteristics. RESULTS: 19.3% of respondents had stage 0/I BC, 68.8% had stage II, 9.4% had stage III, none had stage IV. The most expensive OOP elements were targeted therapy with mean cost equal to 649.5 million VND ($28,025) and chemotherapy at 36.5 million VND ($1575). Mean total OOP cost related to diagnosis and initial BC treatment (excluding targeted therapy cost) was 61.8 million VND ($2667). The mean OOP costs among patients with stage II and III BC were, respectively, 66 and 148% higher than stage 0/I. CONCLUSIONS: BC patients in Vietnam incur significant OOP costs. The cost of BC treatment was driven by the use of therapies and presentation stage at diagnosis. It is likely that OOP costs of BC patients would be reduced by earlier detection through raised awareness and screening programmes and by providing a higher insurance reimbursement rate for targeted therapy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-12448-3. BioMed Central 2022-01-10 /pmc/articles/PMC8750856/ /pubmed/35012517 http://dx.doi.org/10.1186/s12889-021-12448-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Ngan, Tran Thu Ngoc, Nguyen Bao Van Minh, Hoang Donnelly, Michael O’Neill, Ciaran Costs of breast cancer treatment incurred by women in Vietnam |
title | Costs of breast cancer treatment incurred by women in Vietnam |
title_full | Costs of breast cancer treatment incurred by women in Vietnam |
title_fullStr | Costs of breast cancer treatment incurred by women in Vietnam |
title_full_unstemmed | Costs of breast cancer treatment incurred by women in Vietnam |
title_short | Costs of breast cancer treatment incurred by women in Vietnam |
title_sort | costs of breast cancer treatment incurred by women in vietnam |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750856/ https://www.ncbi.nlm.nih.gov/pubmed/35012517 http://dx.doi.org/10.1186/s12889-021-12448-3 |
work_keys_str_mv | AT ngantranthu costsofbreastcancertreatmentincurredbywomeninvietnam AT ngocnguyenbao costsofbreastcancertreatmentincurredbywomeninvietnam AT vanminhhoang costsofbreastcancertreatmentincurredbywomeninvietnam AT donnellymichael costsofbreastcancertreatmentincurredbywomeninvietnam AT oneillciaran costsofbreastcancertreatmentincurredbywomeninvietnam |